NCT04892628

Brief Summary

This study aims to assess the effects of progressive resistance training compared with aerobic training, among those with hemophilia. Participants will be divided into two groups. The control group will receive an aerobic exercise protocol, and the resistance group will follow a resistance training program. Each group will receive a total of eight sessions. Target muscles are deltoids, biceps, triceps, quadriceps, hamstrings, and calves. Subjective and objective assessment will be performed for each group, to determine the effectiveness of each intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable quality-of-life

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable quality-of-life

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 3, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 4, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 19, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

March 23, 2022

Status Verified

March 1, 2022

Enrollment Period

6 months

First QC Date

May 4, 2021

Last Update Submit

March 22, 2022

Conditions

Keywords

Hemophiliaresistance trainingaerobic exercisePakistan

Outcome Measures

Primary Outcomes (4)

  • Manual Muscle Testing - Daniel & Worthingham's

    An objective marker to determine muscle strength. It ranges from 0-5 0 no movement of muscle 1. flickering movement of muscle 2. full range of motion in a gravity minimized position 3. full range of motion against gravity, without resistance 4. muscle can hold against moderate resistance 5. muscle can hold against maximal resistance

    baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)

  • Hemophilia Joint Health Score (HJHS v2.1)

    The HJHS measures joint health, in the domain of body structure and function (i.e. impairment), of the joints most commonly affected by bleeding in hemophilia: the knees, ankles, and elbows. It can be used when there is a need for orthopedic intervention, or as an outcome measure of physiotherapy interventions. A scoring system is present, which combines the score of these questions, with a global gait score, to give an overall score. The greater the score, the poorer the outcome. The HJHS 2.1 provides a total score (higher score is worse; max=124), joint specific scores, and a global gait score.

    baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)

  • Borg Rating of Perceived Exertion

    The second subjective marker. This will be used to assess the subjective workload of exercises, and to note if exercise intensity decreases over time. The values range from 6-20, with 6 rated as 'no exertion', and 20 rated as 'maximal exertion'.

    baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)

  • HEP-Test-Q (Hemophilia and Exercise Project)

    The subjective marker of this study. This measure will assess the quality of life. It is a scale specifically designed for people with hemophilia. The HEP-Test-Q consists of 25 items pertaining to 4 domains 'mobility', 'strength \& coordination', 'endurance' and 'body perception' and one single item, which assesses changes in physical functioning in comparison to the previous year. The recall period for the assessment of physical functioning is over "the past four weeks". The response options range on a 5-point Likert scale from "never" to "always". Some of the items have to be re-coded. Subscales and the total score are transformed to a scale of 0-100 with high scores indicating better physical functioning.

    baseline and post intervention (week 8 - the analysis will be conducted on the first week immediately after the end of the training)

Study Arms (2)

Aerobic training group

OTHER

The control group will be administered a standard physical therapy intervention program which will consist of active muscle stretching and aerobic exercises. Exercises will include: * Flexion, extension and abduction at the shoulder joint for anterior, middle and posterior fibers of deltoid * Flexion and extension at the elbow for biceps and triceps trachii * Flexion and extension at the knee joint for quadriceps and hamstring muscles * Plantar flexion at the ankle joint for gastrocnemius and soleus Three sets of ten repetitions of each exercise will be done.

Other: Aerobic training

Resistance training group

EXPERIMENTAL

The intervention group will undergo a progressive resistance training program consisting of active muscle stretching and resistance training. Exercise for intervention group will consist of: * Resisted flexion, extension and abduction at the shoulder joint for anterior, middle and posterior deltoid, using dumbbells * Resisted flexion and extension at the elbow for biceps and triceps trachii, using dumbbells * Resisted flexion and extension of knee joint for quadriceps and hamstring muscles, using therabands * Resisted dorsiflexion and plantar flexion of gastrocnemius and soleus, using therabands Resistance will be increased on basis of progressive overload principle. Three sets of ten repetitions will be performed per muscle group. Initial weight of the dumbbells will be 1kg and will be increased by 0.5kg per week.

Other: Progressive resistance training

Interventions

Resistance training of upper limb and lower limb muscles. Resistance will be increased on a weekly basis. Dumbbells and therabands will be used to provide resistance.

Resistance training group

The control group will be administered a standard physical therapy intervention program which will consist of active muscle stretching and aerobic exercises.

Aerobic training group

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • clinically diagnosed with hemophilia A or B (mild to moderate hemophilia (mild hemophilia - 0.05-0.4 IU, moderate hemophilia - 0.01-0.05 IU)
  • undergo pre- and post-program objective assessment of manual muscle testing and Hemophilia Joint Health Score, as well as subjective assessment of and Rating of Perceived Exertion.
  • willing to train two times a week
  • males and females between 18 to 45 years of age.
  • those who can ambulate without assistance

You may not qualify if:

  • unable to attend exercise sessions for the complete duration of the study
  • those who have had surgery performed 6 weeks before, or in duration of training (due to any disability)
  • involvement in any other training, or rehabilitation, during study
  • change in medicine within the study
  • history of major bleeding episodes that could pose a risk
  • history of factor 8 or factor 9 inhibitor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hemophilia welfare society karachi

Karachi, Sindh, Pakistan

Location

Related Publications (1)

  • Parhampour B, Dadgoo M, Vasaghi-Gharamaleki B, Torkaman G, Ravanbod R, Mirzaii-Dizgah I, Reza Baghaipour M, Saneii SH. The effects of six-week resistance, aerobic and combined exercises on the pro-inflammatory and anti-inflammatory markers in overweight patients with moderate haemophilia A: A randomized controlled trial. Haemophilia. 2019 Jul;25(4):e257-e266. doi: 10.1111/hae.13764. Epub 2019 May 26.

    PMID: 31131517BACKGROUND

MeSH Terms

Conditions

Muscle WeaknessHemophilia A

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsBlood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Pereira

    Dow University of Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator - Postgraduate Trainee

Study Record Dates

First Submitted

May 4, 2021

First Posted

May 19, 2021

Study Start

April 3, 2021

Primary Completion

September 30, 2021

Study Completion

September 30, 2021

Last Updated

March 23, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations